# Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)

> **NCT03887884** · PHASE1 · COMPLETED · sponsor: **Acorda Therapeutics** · enrollment: 23 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** CVT-301
- **DRUG:** Sinemet

## Key facts

- **NCT ID:** NCT03887884
- **Lead sponsor:** Acorda Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-05
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-28
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2019-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03887884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03887884, "Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03887884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*